Group 1 - Company Amway Co., Ltd. (SZ 300218) announced on November 14 that its seventh board meeting was held to discuss the proposal for the re-election of members of the audit committee [1] - For the year 2024, Amway's revenue composition is as follows: synthetic leather accounts for 98.35%, while other businesses account for 1.65% [1] - As of the report date, Amway's market capitalization is 4 billion yuan [1]

Group 1 - The core viewpoint of the news is that 双象股份 experienced a slight decline in stock price and notable changes in financing activities on November 11, with a net financing outflow [1] - As of November 11, 双象股份 had a total financing and margin trading balance of 159 million yuan, which accounts for 3.33% of its circulating market value, indicating a high level compared to the past year [1] - The company reported a financing buy-in of 4.44 million yuan and a financing repayment of 7.70 million yuan on the same day, resulting in a net financing buy-in of -3.26 million yuan [1] Group 2 - As of October 31, 双象股份 had 14,800 shareholders, a decrease of 3.29% from the previous period, while the average circulating shares per person increased by 3.40% to 18,110 shares [2] - For the period from January to September 2025, 双象股份 achieved an operating income of 1.914 billion yuan, representing a year-on-year growth of 19.32%, and a net profit attributable to shareholders of 182 million yuan, which is a significant increase of 121.32% year-on-year [2] Group 3 - Since its A-share listing, 双象股份 has distributed a total of 256 million yuan in dividends, with 67.05 million yuan distributed over the past three years [3]

Core Viewpoint - Amway Co., Ltd. (SZ 300218) announced an investor survey scheduled for November 11, 2025, where company executives will address investor inquiries [1] Group 1: Company Overview - Amway's revenue composition for the year 2024 is as follows: synthetic leather accounts for 98.35% and other businesses account for 1.65% [1] - As of the report, Amway's market capitalization stands at 3.9 billion yuan [1]

Group 1 - Amway Co., Ltd. (SZ 300218) announced that it will accept a research visit from Industrial Securities on October 31, 2025, with participation from the company's board secretary and deputy general manager, Liu Songxia, to address investor inquiries [1] - For the year 2024, Amway's revenue composition is as follows: synthetic leather accounts for 98.35% and other businesses account for 1.65% [1] - As of the report, Amway's market capitalization stands at 3.7 billion yuan [1]

Core Viewpoint - Amway Co., Ltd. (SZ 300218) announced an investor survey scheduled for September 17, 2025, where the company’s board secretary Liu Songxia will participate in addressing investor inquiries [1] Group 1: Company Overview - For the fiscal year 2024, Amway's revenue composition is as follows: synthetic leather accounts for 98.35% and other businesses account for 1.65% [1] - As of the report, Amway's market capitalization stands at 4.3 billion yuan [1]

Company Overview - Amway Co., Ltd. (SZ 300218) announced that on September 5, 2025, it will accept investor research from Guohai Securities and others, with participation from the company's board secretary and deputy general manager, Liu Songxia [1] - As of the report, Amway's market capitalization stands at 4.7 billion yuan [1] Financial Performance - For the year 2024, Amway's revenue composition is as follows: synthetic leather accounts for 98.35% and other businesses account for 1.65% [1]

Group 1 - The company reported a revenue of 1.215 billion yuan for the first half of 2025, representing a year-on-year increase of 23.71% [1] - The net profit attributable to shareholders reached 134 million yuan, a significant year-on-year growth of 166.61%, indicating improved operational quality [1] - The optical-grade PMMA/MS materials segment achieved a revenue of 872 million yuan, with a year-on-year growth of 35.21% and a gross margin of 18.69%, up 7.07% year-on-year, serving as the core driver of performance growth [1] Group 2 - The synthetic leather segment generated a revenue of 326 million yuan, with a gross margin increase to 17.55%, benefiting from product structure optimization and cost control [2] - The hazardous waste treatment business reported revenue of 17.78 million yuan, a year-on-year increase of 82.9%, becoming a new profit growth point [2] - Export revenue reached 152 million yuan, a year-on-year increase of 74.1%, with significant growth in domestic markets, particularly in Central, North, and Northeast China [2] Group 3 - R&D expenses amounted to 45.1 million yuan, a year-on-year increase of 38.7%, focusing on optimizing optical material performance and improving eco-friendly synthetic leather processes [3] - The company has obtained numerous national invention patents and is involved in various national and provincial research projects, strengthening its technological barriers [3] - Future strategies include accelerating PMMA/MS capacity release, enhancing synthetic leather quality, expanding hazardous waste business, and increasing R&D investment to improve core competitiveness [3]

Group 1 - Company Amway Co., Ltd. (SZ 300218) announced on August 25 that its seventh board meeting was held on August 22, 2025, to discuss the proposal for the second extraordinary shareholders' meeting of 2025 [1] - For the year 2024, Amway's revenue composition is as follows: synthetic leather accounts for 98.35%, while other businesses account for 1.65% [1] - As of the report date, Amway's market capitalization is 5.2 billion yuan [1]

Core Viewpoint - Amway Co., Ltd. has officially launched the remaining two dry production lines in Vietnam, marking a significant expansion in its production capacity [2]. Group 1: Company Developments - Amway Vietnam has completed the installation, debugging, and trial production of the remaining two dry production lines, which are now in full operation [2]. - For the fiscal year 2024, Amway Co., Ltd. projects that its revenue composition will be 98.35% from synthetic leather and 1.65% from other businesses [2].

Group 1 - Amway Co., Ltd. (SZ 300218, closing price: 23.74 CNY) announced that it will accept investor research on August 8, 2025, from 16:00 to 17:30, with participation from the company's board secretary and deputy general manager Liu Songxia and securities affairs representative Chen Liting [2] - For the year 2024, Amway's revenue composition is as follows: synthetic leather accounts for 98.35%, while other businesses account for 1.65% [2]